Lightnews — Scholar-powered news

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · 5d

great HTN JC discussion today on BAXHTN study by Dr. Shawna Nesbitt joined by @dramitkhera.bsky.social @giaconajohn.bsky.social @utswim.bsky.social Interesting that baseline aldosterone in the trial was around 7.5 ng/dL by LCMS with baseline PRA is 1 ng/mlhr. This means that majority of pts have PA

1 3

John Giacona, PhD, PA-C @giaconajohn.bsky.social · 5d

🏆 First time at Epic Cosmos Datathon—our team took 1st place! Grateful for the collaboration and hands on experience ! @drwanpen.bsky.social Excited to present tomorrow (Oct 3) at Pegasus Park Symposium on “Missed Opportunities: Screening for Primary Aldosteronism” #EpicCosmos #HTN

1 4

Reposted by John Giacona, PhD, PA-C

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 6d

Excellent commmentary from @giaconajohn.bsky.social and @drwanpen.bsky.social

1 1 5

Reposted by John Giacona, PhD, PA-C

American Journal of Hypertension @amjhypertension.bsky.social · 6d

Comparing Management strategies for Primary Aldosteronism: Is it 🍎 versus 🍊 ?

Commentary academic.oup.com/ajh/article-...

based on
academic.oup.com/ajh/article-...

#Hypertension #Aldosteronism

Optimal Treatment of Primary Aldosteronism: Can We Compare Apples to Oranges?

Primary aldosteronism (PA) is an endocrine disorder characterized by inappropriate and excessive aldosterone production.1 PA is a prevalent cause of elevat

academic.oup.com

2 3 6

John Giacona, PhD, PA-C @giaconajohn.bsky.social · 9d

Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>

7 7

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · 15d

Our new study that links high Phosphate diet found in processed food and anxiety behavior and alternation of genes involved in mood regulation in mice. That may explain why we don't feel good after a whopper or a big Mac @hkkimphd.bsky.social @utswim.bsky.social sciencedirect.com/science/arti...

1 6

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · 26d

great HTN journal club discussing GWAS in primary aldosteronism by @jdmosley-moses.bsky.social @giaconajohn.bsky.social www.ahajournals.org/doi/10.1161/...

1 9

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 7

So much fun AHA #Hypertension25 gala dinner learning history of HTN from Bill Cushman and visiting with friends @anastasiasmihaili.bsky.social @giaconajohn.bsky.social @spjuraschek.bsky.social

2 9

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Sep 6

Thank you, Dr. Yuan , and the program committee @drwanpen.bsky.social , and @tammybrady.bsky.social for the opportunity to discuss this important topic!

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 6

@giaconajohn.bsky.social excellent talk highlights that intensive lowering of BP leads to lower not higher risk of OH based on metaanalysis of RCT by @spjuraschek.bsky.social #Hypertension25 Rx should be titrated to seated BP in OH as per 2025 high BP guidelines

2 4 6

Reposted by John Giacona, PhD, PA-C

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · Sep 6

Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social
#Nephpearls #NephSky #ESCCongress

👉 journals.lww.com/jasn/fulltex...

4 5

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 6

Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang

3 8

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 5

Dr Karol Watson starts with impactful message top 10 take away message #Hypertension25 high BP as predictor dementia and treatment reduces cognitive decline or dementia by 15% . Once you hit 120/80 , trajectory to high BP is steep. Don’t sit on high BP! @ahascience.bsky.social

3 7

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Sep 5

Ideal BP < 120/80 mmHg! #Hypertension25

7

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 5

Congratulations @robynwei.bsky.social RD/ PhD candidate for her poster #Hypertension25 highlighting underutilization of salt substitute use in the US @giaconajohn.bsky.social details in AHA News release newsroom.heart.org/news/u-s-sur... @ahascience.bsky.social

3 9

Reposted by John Giacona, PhD, PA-C

robynwei.bsky.social @robynwei.bsky.social · Sep 5

Honored to present my abstract poster at the AHA #hypertension25 on the prevalence of salt substitute use. Grateful that our work @drwanpen.bsky.social @giaconajohn.bsky.social
@jesslin23.bsky.social was also featured in the official AHA news release: newsroom.heart.org/news/u-s-sur...

U.S. survey finds salt substitutes rarely used by people with high blood pressure

Research Highlights: Despite their effectiveness in lowering sodium intake and managing blood pressure, salt substitutes were rarely used by people with high blood pressure, according to a review of a...

newsroom.heart.org

3 5

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Sep 5

Kicked off the day with a run around Baltimore Harbor 🌊🏃‍♂️ at #Hypertension25. A reminder that movement matters — let’s keep championing lifestyle and physical activity as powerful tools to reduce CVD and BP! @ahascience.bsky.social

3

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Sep 5

Outstanding review of resistant hypertension at #HTN25 by Drs. @drwanpen.bsky.social , Keith Ferdinand, and Ty Gluckman — from current challenges in care to exciting new agents in the pipeline. Great insights into where the field is heading!

1 2

Reposted by John Giacona, PhD, PA-C

Jesslin Abraham, M.D. @jesslin23.bsky.social · Sep 4

Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social
@robynwei.bsky.social

1 3 7

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 4

Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social

4 7

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Sep 4

Fantastic opening session at AHA #HTN25 — great energy, insights, and inspiration already flowing. Excited for the great science and rich discussions ahead! @ahascience.bsky.social @drwanpen.bsky.social

1

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Sep 3

Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social

6 12

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Aug 28

❓What’s new in BP care?
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org

3 9

Reposted by John Giacona, PhD, PA-C

Wanpen Vongpatanasin @drwanpen.bsky.social · Aug 19

Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart

7 9

John Giacona, PhD, PA-C @giaconajohn.bsky.social · Aug 14

New 2025 AHA/ACC Hypertension Guidelines are out! You will not want to miss this webinar! Sign up 👇

Wanpen Vongpatanasin @drwanpen.bsky.social · Aug 14

The 2025 AHA/ACC Hypertension GL is out ! @CircAHA www.ahajournals.org/doi/10.1161/... please join us for the Targetbp Webinar as the first platform to digest the GL by @kcferdmd @jordybc.bsky.social and Dan Jones targetbp.org/events/ on August 28

2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of...

AIM: The “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” retires and replaces the...

www.ahajournals.org